Dr Andreas Wicki

Member of the Board of Directors and Chief Executive Officer of HBM Partners Ltd

Successful healthcare entrepreneur and investor with over 15 years of experience in the pharmaceutical and biotechnology industries. He was co-owner and CEO of ANAWA Holding AG and Clinserve AG, two Contract Research Organisations specialising in analytical services. MSc and PhD in chemistry and biochemistry from the University of Berne, Switzerland. Board of Directors of Buchler GmbH, Pacira Inc., PharmaSwiss SA, HBM Partners Ltd. and HBM BioVentures (Cayman) Ltd.

back

News

PTC licenses Spinal Muscular Atrophy programme to Roche (12 KB)
Ellipse receives award for best new technology in spine care (29 KB)
Probiodrug announces top-line results of the first clinical study of PQ912 for treatment of Alzheimer's disease (44 KB)

M&A Report

HBM Pharma/Biotech M&A Report

Links

HBM BioVentures

Subscribe To Our Newsletter

Subscribe here

TOP|
SITEMAP|
CREDITS|
IMPORTANT LEGAL INFORMATION

http://www.hbmpartners.com/en/about-hbm-partners/partners/wicki-andreas.php